Dehydroepiandrosterone (DHEA) treatment of depression

Biological Psychiatry

Volumn 41, Issue 3, 1997, Pages 311-318

  Wolkowitz, Owen M ^a,b   Reus, Victor I ^a   Roberts, Eugene ^b   Manfredi, Francesca ^a   Chan, Theresa ^a   Raum, William J ^c   Ormiston, Susan ^a   Johnson, Ronald ^a   Canick, Jonathan ^a   Brizendine, Louann ^a   Weingartner, Herbert ^d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

cortisol; depression; DHEA; DHEA S; memory

Indexed keywords

HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MEMORY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; ANTIDEPRESSIVE AGENTS; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; MALE; MEMORY; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 0031081775     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00043-1     Document Type: Article

References (55)

1. Abadie JM, Wright B, Correa G, Browne ES, Porter JR, Svec F (1993): Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. Diabetes 42:662-669.
2. Arnetz BB, Theorell T, Levi L, Kallner A, Eneroth P (1983): An experimental study of social isolation of elderly people: Psychoendocrine and metabolic effects. Psychosom Med 45:395-406.
3. Berkman LF, Seeman TE, Albert M, Blazer D, Kahn R, Mohs R, Finch C, Schneider E, Cotman C, McClearn G, et al. (1993): High, usual and impaired functioning in community dwelling older men and women: Findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol 46:1129-1140.
4. Bonnet KA, Brown RP (1990): Cognitive effects of DHEA replacement therapy. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 65-80.
5. Browne ES, Wright BE, Porter JR, Svec F (1992): Dehydroepiandrosterone: Antiglucocorticoid action in mice. Am J Med Sci 303:366-371.
6. Calabrese VP, Isaacs ER, Regelson W (1990): Dehydroepiandrosterone in multiple sclerosis: positive effects on the fatigue syndrome in a non-randomized study. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 95-100.
7. A receptor. Neuroscience 45:127-135.
8. Fava M, Littman A, Halperin P (1987): Neuroendocrine correlates of the Type A behavior pattern: A review and new hypotheses. Int J Psychiatry Med 17:289-307.
9. Fava M, Littman A, Lamon-Fava S, Milani R, Shera D, MacLaughlin R, Cassem E, Leaf A, Marchio B, Bolognesi E, Guaraldi GP (1992): Psychological, behavioral and biochemical risk factors for coronary artery disease among American and Italian male corporate managers. Am J Cardiol 70:1412-1416.
10. Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M (1989): Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res 28: 345-350.
11. Ferguson HC, Bartram ACG, Fowlie HC, Cathro DM, Birchall K, Mitchell FL (1964): A preliminary investigation of steroid excretion in depressed patients before and after electro-convulsive therapy. Acta Endocrinologica 47:58-66.
12. Flood JF, Morley JE, Roberts E (1992): Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89:1567-1571.
13. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F (1995): DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 268:E107-E113.
14. Glaser JL et al (1992): Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med 15:327-341.
15. Gray A, Jackson DN, McKinlay JB (1991): The relation between dominance, anger, and hormones in normally aging men: Results from the Massachusetts Male Aging Study. Psychosom Med 53:375-385.
16. Hansen Jr CR, Kroll J, Mackenzie TB (1982): Dehydroepiandrosterone and affective disorders. Am J Psychiatry 139:386-387.
17. Hermida RC, Halberg F, Del Pozo F (1985): Chronobiologic pattern discrimination of plasma hormones, notably DHEA-S and TSH, classifies an expansive personality. Chronobiologia 12:105-136.
18. Howard III JS (1992): Severe psychosis and the adrenal androgens. Integr Physiol Behav Sci 27:209-215.
19. Jacoby LL (1991): A process dissociation framework: Separating automatic from intentional uses of memory. J Mem Lang 30:513-541.
20. Kalimi M, Regelson W (eds) (1990): The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter.
21. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W (1994): Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131:99-104.
22. Klinteberg B, Hallman J, Oreland L, Wirsen B, Levander SE, Schalling D (1992): Exploring the connections between platelet monoamine oxidase activity and behavior. II. Impulsive personality without neuropsychological signs of disinhibition in air force pilot recruits. Neuropsychobiology 26:136-145.
23. Koo E, Fehér KG, Fehér T, Füst G (1983): Effect of dehydroepiandrosterone on hereditary angioedema. Klin Wochenschr 61:715-717.
24. Maes M, Meltzer HY (1995): The serotonin hypothesis of major depression. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, Ltd., pp. 933-944.
25. Mellon SH (1994): Neurosteroids: Biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 78:1003-1008.
26. Meyer JH, Gruol DL (1994): Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice. Brain Res 633:253-261.
27. Morales AJ, Nolan JJ, Nelson JC, Yen SSC (1994): Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367.
28. Mortola JF, Yen SSC (1990): The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women. J Clin Endocrinol Metab 71:696-704.
29. Murphy BEP (1991): Steroids and depression. J Steroid Biochem Molec Biol 38:537-558.
30. Murphy BEP, Wolkowitz OM (1993): The pathophysiologic significance of hyperadrenocorticism: antiglucocorticoid strategies. Psychiatr Annals V23:682-690.
31. Näsman, Olsson T, Bäckström, Sriksson S, Grankvist K, Vütanen M, Bucht G (1991): Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 30:684-696.
32. Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988): Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. Clin Endocrinol Metab 66:57-61.
33. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984): Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555.
34. Parker LN (1989): Exercise, stress and illness. In Parker LN, Adrenal Androgens in Clinical Medicine. San Diego: Academic Press, Inc., Harcourt Brace Jovanovich, pp. 450-461.
35. Regelson W, Kalimi M, Loria R (1990): Dehydroepiandrosterone (DHEA): The precursor steroid: Introductory remarks. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 1-6.
36. Reus VI, Wolkowitz OM, Roberts E, Chan T, Turetsky N, Manfredi F, Weingartner H (1993): Dehydroepiandrosterone (DHEA) and memory in depressed patients. Neuropsychopharmacology 9:66S.
37. Riley V, Fitzmaurice MA, Regelson W (1990): DHEA and thymus integrity in the mouse. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 131-156.
38. Roberts E (1990): Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) as neural facilitators: effects on brain tissue in culture and on memory in young and old mice: A cyclic GMP hypothesis of action of DHEA and DHEAS in nervous system and other tissues. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 13-42.
39. Roberts E, Fauble T (1990): Oral dehydroepiandrosterone in multiple sclerosis. Results of a phase one, open study. In Kalimi M, Regelson W (eds), The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 81-94.
40. Roberts E, Fitten LJ (1990): Serum steroid levels in two old men with Alzheimer's disease (AD) before, during and after oral administration of dehydroepiandrosterone (DHEA). Pregnenolone synthesis may be rate-limiting in aging. In The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter, pp. 43-64.
41. Rudman D, Shatty KR, Mattson DE (1990): Plasma dehydroepiandrosterone sulfate in nursing home men. J Am Geriatr Soc 38:421-427.
42. Sands D (1954): Further studies on endocrine treatment in adolescence and early adult life. J Ment Sci 100:211-219.
43. Sands DE, Chamberlain GHA (1952): Treatment of inadequate personality in juveniles by dehydroisoandrosterone. Br Med J 2:66.
44. Sonka J (1976): Dehydroepiandrosterone: Metabolic effects. Acta Universitatis Carolinae Medica Monographia LXXI:6-146.
45. Strauss EB, Sands DE, Robinson AM, Tindall WJ, Stevenson WAH (1952): Use of dehydroisoandrosterone in psychiatric treatment: A preliminary survey. Br Med J 2:64-66.
46. Strauss EB, Stevenson WAH (1955): Use of dehydroisoandrosterone in psychiatric practice. J Neurol Neurosurg Psychiatry 18:137-144.
47. Tariot PN, Weingartner H (1986): A psychobiologic analysis of cognitive failures: Structure and mechanisms. Arch Gen Psychiatry 43:1183-1188.
48. Tollefson GD, Haus E, Garvey MJ, Evans M, Tuason VB (1990): 24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy. Ann Clin Psychiatry 2:39-45.
49. van Vollenhoven RF, Engleman EG, McGuire JL (1994): An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 37:1305-1310.
50. Weingartner HJ, Eckardt M, et al. (1993): The effects of repetition on memory performance in cognitively impaired patients. Neuropsychol Rev 7:385-395.
51. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L (1992a): Antiglucocorticoid strategies in hypercortisolemic states. Psychopharmacol Bull 28:247-251.
52. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H (1993a): Ketoconazole treatment of hypercortisolemic depression. Am J Psychiatry 150:810-812.
53. Wolkowitz OM, Reus VI, Manfredi F, Roberts E (1992b): Antiglucocorticoid effects of DHEA-S in Alzheimer's Disease (Reply). Am J Psychiatry 149:1126.
54. Wolkowitz OM, Reus VI, Roberts E (1993b): Role of DHEA and DHEA-S in Alzheimer's disease (Reply). Am J Psychiatry 150:1433.
55. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D (1990): Cognitive effects of corticosteroids. Am J Psychiatry 147:1297-1303.